Proof of concept that most borderline Quantiferon results are true antigenspecific responses

European Respiratory Journal

Volumn 50, Issue 5, 2017, Pages

  Uzorka, Jonathan W ^a   Kroft, Lucia J M ^a   Bakker, Jaap A ^a   Van Zwet, Erik W ^a   Huisman, Erik ^b   Knetsch Prins, Corine ^a   Van Der Zwan, Cornelis J ^a   Ottenhoff, Tom H M ^a   Arend, Sandra M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GGD Hollands Midden   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; METHOTREXATE; OSTEOCLAST DIFFERENTIATION FACTOR; GAMMA INTERFERON;

ADULT; ANALYSIS OF VARIANCE; ANTIGEN SPECIFICITY; CLINICAL PRACTICE; COMORBIDITY; CONTROLLED STUDY; FEMALE; GOVERNMENT; HEALTH CARE SYSTEM; HUMAN; INTERFERON GAMMA RELEASE ASSAY; KRUSKAL WALLIS TEST; LATENT TUBERCULOSIS; LETTER; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL HEALTH SERVICE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TERTIARY CARE CENTER; AGED; BLOOD; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE; PROOF OF CONCEPT; STANDARDS; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; AGED; FEMALE; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; PROOF OF CONCEPT STUDY; RETROSPECTIVE STUDIES; TUBERCULIN TEST; TUBERCULOSIS;

EID: 85035062055     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01630-2017     Document Type: Letter

References (15)

1. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354.
2. Ringshausen FC, Nienhaus A, Schablon A, et al. Predictors of persistently positive Mycobacterium-tuberculosisspecific interferon-gamma responses in the serial testing of health care workers. BMC Infect Dis 2010; 10: 220.
3. Nienhaus A, Ringshausen FC, Costa JT, et al. IFN-gamma release assay versus tuberculin skin test for monitoring TB infection in healthcare workers. Expert Rev Anti Infect Ther 2013; 11: 37-48.
4. Whitworth WC, Hamilton LR, Goodwin DJ, et al. Within-subject interlaboratory variability of QuantiFERON-TB gold in-tube tests. PLoS One 2012; 7: e43790.
5. Metcalfe JZ, Cattamanchi A, McCulloch CE, et al. Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice. Am J Respir Crit Care Med 2013; 187: 206-211.
6. Tagmouti S, Slater M, Benedetti A, et al. Reproducibility of interferon gamma (IFN-gamma) release assays. A systematic review. Ann Am Thorac Soc 2014; 11: 1267-1276.
7. Leyten EM, Arend SM, Prins C, et al. Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol 2007; 14: 880-885.
8. Mack U, Migliori GB, Sester M, et al. LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J 2009; 33: 956-973.
9. Oxford Immunotec. T-Spot.TB package insert. Marlborough, Oxford Immunotec Inc., 2015. www.tspot.com/wpcontent/ uploads/2012/01/PI-TB-US-v5.pdf
10. American Thoracic Society (ATS); Centers for Disease Control and Prevention (CDC). Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: S221-S247.
11. Qiagen. QuantiFERON-TB Gold Plus. Package Inserts QFT-Plus. www.quantiferon.com/products/quantiferon-tbgold-plus/package-inserts Date last acccessed: October 19, 2017.
12. Barcellini L, Borroni E, Brown J, et al. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening. Eur Respir J 2016; 48: 1411-1419.
13. Barcellini L, Borroni E, Brown J, et al. First independent evaluation of QuantiFERON-TB Plus performance. Eur Respir J 2016; 47: 1587-1590.
14. Hoffmann H, Avsar K, Gores R, et al. Equal sensitivity of the new generation QuantiFERON-TB Gold plus in direct comparison with the previous test version QuantiFERON-TB Gold IT. Clin Microbiol Infect 2016; 22: 701-703.
15. Moon HW, Gaur RL, Tien SS, et al. Evaluation of QuantiFERON(R)-TB Gold-Plus in healthcare workers in a low-incidence setting. J Clin Microbiol 2017; 55: 1650-1657.